Published in Crit Care Med on August 01, 2006
Critical care bed growth in the United States. A comparison of regional and national trends. Am J Respir Crit Care Med (2015) 1.93
ICU occupancy and mechanical ventilator use in the United States. Crit Care Med (2013) 1.87
Trends in end-of-life ICU use among older adults with advanced lung cancer. Chest (2007) 1.76
Arterial hyperoxia and in-hospital mortality after resuscitation from cardiac arrest. Crit Care (2011) 1.55
Organizational determinants of hospital end-of-life treatment intensity. Med Care (2009) 1.45
The assessment of inequality on geographical distribution of non-cardiac intensive care beds in iran. Iran J Public Health (2011) 1.29
Is there a Starling curve for intensive care? Chest (2012) 1.23
The intensive care unit family meeting: making it happen. J Crit Care (2009) 1.19
Clinical review: allocating ventilators during large-scale disasters--problems, planning, and process. Crit Care (2007) 1.08
Utstein-style template for uniform data reporting of acute medical response in disasters. PLoS Curr (2012) 1.05
Factors influencing triage decisions in patients referred for ICU admission. J Clin Med Res (2013) 0.79
Unintended Pregnancy and Its Adverse Social and Economic Consequences on Health System: A Narrative Review Article. Iran J Public Health (2015) 0.76
Once more unto the breach, dear friends, once more. World J Crit Care Med (2012) 0.75
The epidemiology, risk factors, and impact on hospital mortality of status epilepticus after subdural hematoma in the United States. Springerplus (2014) 0.75
ICU Use and Quality of Care for Patients With Myocardial Infarction and Heart Failure. Chest (2016) 0.75
Hospital-Level Changes in Adult ICU Bed Supply in the United States. Crit Care Med (2017) 0.75
Critical care medicine in the United States 2000-2005: an analysis of bed numbers, occupancy rates, payer mix, and costs. Crit Care Med (2010) 6.26
Recommendations for the diagnosis and management of corticosteroid insufficiency in critically ill adult patients: consensus statements from an international task force by the American College of Critical Care Medicine. Crit Care Med (2008) 5.30
Critical care medicine in the United States: addressing the intensivist shortage and image of the specialty. Crit Care Med (2013) 4.76
Phase III study of cisplatin with or without paclitaxel in stage IVB, recurrent, or persistent squamous cell carcinoma of the cervix: a gynecologic oncology group study. J Clin Oncol (2004) 3.85
Critical care medicine in the United States 1985-2000: an analysis of bed numbers, use, and costs. Crit Care Med (2004) 3.62
Practice patterns in choice of left double-lumen tube size for thoracic surgery. Anesth Analg (2008) 3.25
Intrapartum elective cesarean delivery: a previously unrecognized clinical entity. Obstet Gynecol (2004) 2.79
A quantitative measurement of the human somatic mutation rate. Cancer Res (2005) 2.55
Failure of physiologic transformation of the spiral arteries in patients with preterm labor and intact membranes. Am J Obstet Gynecol (2003) 2.55
Recommendations for reporting weight loss. Obes Surg (2003) 2.40
Has survival increased in cancer patients admitted to the ICU? Yes. Intensive Care Med (2014) 2.35
Use of information resources by patients with cancer and their companions. Cancer (2004) 1.93
Statin use is associated with a reduction in atrial fibrillation after noncardiac thoracic surgery independent of C-reactive protein. Chest (2005) 1.85
Immunohistochemically detected tumor cells in the sentinel lymph nodes of patients with breast carcinoma: biologic metastasis or procedural artifact? Cancer (2004) 1.74
Rapid antibiotic delivery and appropriate antibiotic selection reduce length of hospital stay of patients with community-acquired pneumonia: link between quality of care and resource utilization. Arch Intern Med (2002) 1.73
Critical care medicine use and cost among Medicare beneficiaries 1995-2000: major discrepancies between two United States federal Medicare databases. Crit Care Med (2007) 1.73
Leukocytosis and increased risk of atrial fibrillation after general thoracic surgery. Ann Thorac Surg (2006) 1.70
Brugada electrocardiographic pattern in a postoperative patient. Crit Care Med (2005) 1.64
Celecoxib, a selective cyclooxygenase 2 inhibitor, protects against human epidermal growth factor receptor 2 (HER-2)/neu-induced breast cancer. Cancer Res (2002) 1.59
Failure of physiologic transformation of the spiral arteries in the placental bed in preterm premature rupture of membranes. Am J Obstet Gynecol (2002) 1.58
Celecoxib inhibits prostate cancer growth: evidence of a cyclooxygenase-2-independent mechanism. Clin Cancer Res (2005) 1.55
Smoking and timing of cessation: impact on pulmonary complications after thoracotomy. Chest (2005) 1.49
Structure, process, and annual ICU mortality across 69 centers: United States Critical Illness and Injury Trials Group Critical Illness Outcomes Study. Crit Care Med (2014) 1.48
Influence of preoperative exercise capacity on length of stay after thoracic cancer surgery. Ann Thorac Surg (2007) 1.46
Clinical prediction rule for atrial fibrillation after coronary artery bypass grafting. J Am Coll Cardiol (2004) 1.46
Inflammation and outcome after general thoracic surgery. Eur J Cardiothorac Surg (2007) 1.45
Factors associated with pneumothorax and pneumothorax requiring treatment after percutaneous lung biopsy in 443 consecutive patients. J Vasc Interv Radiol (2004) 1.44
Tumor associated endothelial expression of B7-H3 predicts survival in ovarian carcinomas. Mod Pathol (2010) 1.44
Metachronous skeletal osteosarcoma in patients treated with adjuvant and neoadjuvant chemotherapy for nonmetastatic osteosarcoma. J Clin Oncol (2003) 1.44
A clinical prediction rule for pulmonary complications after thoracic surgery for primary lung cancer. Anesth Analg (2009) 1.43
Is there an increased incidence of contralateral testicular cancer in patients with intratesticular microlithiasis? AJR Am J Roentgenol (2003) 1.42
Utilization of critical care services among patients undergoing total hip and knee arthroplasty: epidemiology and risk factors. Anesthesiology (2012) 1.41
QTc interval prolongation associated with intravenous methadone. Pain (2003) 1.40
The development of a validated instrument to evaluate bowel function after sphincter-preserving surgery for rectal cancer. Dis Colon Rectum (2005) 1.37
The measurement of symptoms in young children with cancer: the validation of the Memorial Symptom Assessment Scale in children aged 7-12. J Pain Symptom Manage (2002) 1.36
Steroid treatment in ARDS: a critical appraisal of the ARDS network trial and the recent literature. Intensive Care Med (2007) 1.36
HER2/neu-induced mammary tumorigenesis and angiogenesis are reduced in cyclooxygenase-2 knockout mice. Cancer Res (2005) 1.32
Cognitive functions in primary CNS lymphoma after single or combined modality regimens. Neuro Oncol (2011) 1.25
Osteogenic and Ewing sarcomas: estimation of necrotic fraction during induction chemotherapy with dynamic contrast-enhanced MR imaging. Radiology (2003) 1.22
Imaging of HSV-tk Reporter gene expression: comparison between [18F]FEAU, [18F]FFEAU, and other imaging probes. J Nucl Med (2008) 1.14
Shorter symptom assessment instruments: the Condensed Memorial Symptom Assessment Scale (CMSAS). Cancer Invest (2004) 1.14
Quality of life (QOL) outcomes from a randomized trial of cisplatin versus cisplatin plus paclitaxel in advanced cervical cancer: a Gynecologic Oncology Group study. Gynecol Oncol (2006) 1.14
Dynamic contrast-enhanced magnetic resonance imaging as a predictor of outcome in head-and-neck squamous cell carcinoma patients with nodal metastases. Int J Radiat Oncol Biol Phys (2011) 1.14
Chemotherapy induces the expression of cyclooxygenase-2 in non-small cell lung cancer. Clin Cancer Res (2005) 1.13
Early detection and prognosis of ovarian cancer using serum YKL-40. J Clin Oncol (2004) 1.09
Real-time imaging of HIF-1alpha stabilization and degradation. PLoS One (2009) 1.09
Advance directives in an oncologic intensive care unit: a contemporary analysis of their frequency, type, and impact. J Palliat Med (2011) 1.09
Sensory morbidity after sentinel lymph node biopsy and axillary dissection: a prospective study of 233 women. Ann Surg Oncol (2002) 1.09
Prevalence and mortality of acute lung injury and ARDS after lung resection. Chest (2006) 1.07
A world without ventilator-associated pneumonia: time to abandon surveillance and deconstruct the bundle. Crit Care Med (2012) 1.07
On the prevalence of M. avium subspecies paratuberculosis DNA in the blood of healthy individuals and patients with inflammatory bowel disease. PLoS One (2008) 1.04
Quality of life and symptom control after stent placement or surgical palliation of malignant colorectal obstruction. J Am Coll Surg (2010) 1.03
First- and second-trimester ultrasound assessment of gestational age. Am J Obstet Gynecol (2004) 1.03
Review of a large clinical series: intrahospital transport of critically ill patients: outcomes, timing, and patterns. J Intensive Care Med (2009) 1.00
Distinction of endometrial stromal sarcomas from 'hemangiopericytomatous' tumors using a panel of immunohistochemical stains. Mod Pathol (2005) 0.98
Average arterial input function for quantitative dynamic contrast enhanced magnetic resonance imaging of neck nodal metastases. BMC Med Phys (2009) 0.97
Treatment of YAC128 mice and their wild-type littermates with cystamine does not lead to its accumulation in plasma or brain: implications for the treatment of Huntington disease. J Neurochem (2005) 0.97
Early specialty palliative care. N Engl J Med (2014) 0.97
Longitudinal cognitive follow-up in low grade gliomas. J Neurooncol (2007) 0.97
Multimodality imaging of TGFbeta signaling in breast cancer metastases. FASEB J (2009) 0.97
Cognitive functions in low-grade gliomas: disease and treatment effects. J Neurooncol (2006) 0.96
Is intrathecal methotrexate necessary in the treatment of primary CNS lymphoma? J Neurooncol (2002) 0.96
Serous endometrial cancers that mimic endometrioid adenocarcinomas: a clinicopathologic and immunohistochemical study of a group of problematic cases. Am J Surg Pathol (2004) 0.94
Preoperative left atrial dysfunction and risk of postoperative atrial fibrillation complicating thoracic surgery. J Thorac Cardiovasc Surg (2011) 0.93
Predictors of intensive care unit admission and related outcome for patients after pancreaticoduodenectomy. J Gastrointest Surg (2005) 0.91
Weight loss reporting. Obes Surg (2008) 0.91
High incidence of thrombosis in African-American and Latin-American patients with Paroxysmal Nocturnal Haemoglobinuria. Thromb Haemost (2005) 0.91
Critical Care Medicine Beds, Use, Occupancy, and Costs in the United States: A Methodological Review. Crit Care Med (2015) 0.89
Inhibition of Jun NH2-terminal kinases suppresses the growth of experimental head and neck squamous cell carcinoma. Clin Cancer Res (2007) 0.89
Brain natriuretic peptide and risk of atrial fibrillation after thoracic surgery. J Thorac Cardiovasc Surg (2012) 0.87
Thrombolytic therapy is effective in paroxysmal nocturnal hemoglobinuria: a series of nine patients and a review of the literature. Haematologica (2011) 0.87
Identification of novel prognosticators of outcome in squamous cell carcinoma of the head and neck. J Clin Oncol (2004) 0.86
Corticosteroids in ARDS: a counterpoint. Chest (2007) 0.86
Memorial symptom assessment scale. Expert Rev Pharmacoecon Outcomes Res (2004) 0.85
Trends in Critical Care Beds and Use Among Population Groups and Medicare and Medicaid Beneficiaries in the United States: 2000-2010. Crit Care Med (2016) 0.85
Cost-effectiveness analysis of robotically assisted laparoscopy for newly diagnosed uterine cancers. Obstet Gynecol (2014) 0.85
Imaging the norepinephrine transporter in neuroblastoma: a comparison of [18F]-MFBG and 123I-MIBG. Clin Cancer Res (2014) 0.85
A national ICU telemedicine survey: validation and results. Chest (2012) 0.83
Protocols and Hospital Mortality in Critically Ill Patients: The United States Critical Illness and Injury Trials Group Critical Illness Outcomes Study. Crit Care Med (2015) 0.83
Transfusion therapy and acute lung injury. Expert Rev Respir Med (2010) 0.83
Treating morbid obesity with laparoscopic adjustable gastric banding. Am J Surg (2007) 0.82
Implantable gastric stimulation (IGS) as therapy for human morbid obesity: report from the 2001 IFSO symposium in Crete. Obes Surg (2002) 0.81
Trastuzumab interruption and treatment-induced cardiotoxicity in early HER2-positive breast cancer. Breast Cancer Res Treat (2015) 0.80
Management dilemmas due to a paratracheal follicular dendritic cell tumor. Ann Thorac Surg (2006) 0.80
CA125 regression in ovarian cancer patients treated with intravenous versus intraperitoneal platinum-based chemotherapy: a gynecologic oncology group study. Gynecol Oncol (2011) 0.79
Presence of prolonged dispersion of qt intervals in late survivors of childhood anthracycline therapy. Pediatr Hematol Oncol (2002) 0.79
Quality of virtual colonoscopy in patients who have undergone radiation therapy or surgery: how successful are we? AJR Am J Roentgenol (2002) 0.79
Corticosteroids for septic shock. N Engl J Med (2008) 0.79
Cognitive functions in long-term survivors of ovarian cancer. Gynecol Oncol (2010) 0.79
ACP journal club. Dalteparin was at least as effective as UFH for VTE prevention in critically ill patients, with similar costs. Ann Intern Med (2015) 0.78
Homeward bound: an analysis of patients discharged home from an oncologic intensive care unit. J Crit Care (2012) 0.78
Critical care medicine advanced practice provider model at a comprehensive cancer center: successes and challenges. Am J Crit Care (2013) 0.78
Effect of a Western-style diet fortified with increased calcium and vitamin D on mammary gland of C57BL/6 mice. J Med Food (2008) 0.78
ICU admissions after actual or planned hospital discharge: incidence, clinical characteristics, and outcomes in patients with cancer. Chest (2009) 0.78